MapLight Therapeutics
MPLT· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Christopher A. Kroeger, M.D. is the CEO of MapLight Therapeutics and was paid $25.6M in FY2025 (Dec), up 192%.
PayNo stock prices for these years
Executives3
See all- 1Christopher A. Kroeger, M.D.President and Chief Executive OfficerFY2025
- 2Erin Pennock Foff, M.D., Ph.D.Chief Medical OfficerFY2025
- 3Vishwas SetiaChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMapLight Therapeutics paid its 3 named executives $38.1M in total in FY2025 (Dec). CEO Christopher A. Kroeger, M.D. was paid $25.6M of that.
| Name | ||
|---|---|---|
| Christopher A. Kroeger, M.D.President and Chief Executive Officer | ||
| Erin Pennock Foff, M.D., Ph.D.Chief Medical Officer | ||
| Vishwas SetiaChief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for MapLight Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Timothy GarnettDirector · 2 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
- Nanna LüneborgDirector · 0 yr on the boardIndependentAudit, Compensation—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings2
See all| Proxy statement | DEF 14A | Apr 29, 2026 | FY2025 |
| Annual report | 10-K | Mar 26, 2026 | FY2025 |
